Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,367 | 31,658 | 23,071 | 3,363 | 3,081 |
| Marketable Securities | 18,320 | 8,701 | 9,303 | 24,503 | 24,807 |
| Receivables | 22,469 | 25,380 | 28,322 | 31,310 | 30,841 |
| Inventories | 9,614 | 10,576 | 11,118 | 11,016 | 11,278 |
| TOTAL | $70,247 | $79,736 | $74,690 | $73,270 | $72,927 |
| Non-Current Assets | |||||
| PPE Net | 2,882 | 3,116 | 3,295 | 3,476 | 3,587 |
| Other Non-Current Assets | 28,373 | 1,849 | 1,842 | 1,831 | 1,608 |
| TOTAL | $31,255 | $4,965 | $5,137 | $5,307 | $5,195 |
| Total Assets | $101,502 | $84,701 | $79,827 | $78,577 | $78,122 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,144 | 4,291 | 5,452 | 5,843 | 5,269 |
| Accrued Expenses | 14,720 | 30,104 | 28,523 | 29,539 | 27,899 |
| Other current liabilities | 1,728 | 1,994 | 1,739 | 1,764 | 1,934 |
| TOTAL | $20,592 | $36,389 | $35,714 | $37,146 | $35,102 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,382 | 2,450 | 2,433 | 2,497 | 1,626 |
| TOTAL | $2,382 | $2,450 | $2,433 | $2,497 | $1,626 |
| Total Liabilities | $22,974 | $38,839 | $38,147 | $39,643 | $36,728 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,527 | 34,526 | 34,526 | 34,526 | N/A |
| Common Shares | 35 | 35 | 35 | 35 | 35 |
| Retained earnings | -205,437 | -237,967 | -242,174 | -244,658 | -242,338 |
| Other shareholders' equity | -259 | -330 | -230 | -419 | -208 |
| TOTAL | $78,528 | $45,862 | $41,680 | $38,934 | $41,394 |
| Total Liabilities And Equity | $101,502 | $84,701 | $79,827 | $78,577 | $78,122 |